Oxford Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Oxford Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,707	Closed	-$225K	–	404
2026 Q1	$225K	Buy	+3,707	New	+$216K	0.09%	332
2025 Q4	–	Sell	-47,603	Closed	-$2.15M	–	529
2025 Q3	$2.15M	Buy	+47,603	New	+$2.22M	0.7%	22
2024 Q3	–	Sell	-24,196	Closed	-$1M	–	325
2024 Q2	$1M	Buy	+24,196	New	+$1.08M	0.98%	18
2024 Q1	–	Sell	-20,713	Closed	-$1.06M	–	271
2023 Q4	$1.06M	Buy	+20,713	New	+$1.09M	1.59%	4
2020 Q1	–	Sell	-133,014	Closed	-$8.54M	–	357
2019 Q4	$8.54M	Buy	+133,014	New	+$7.62M	0.24%	91
2019 Q3	–	Sell	-72,390	Closed	-$10.9M	–	1718
2019 Q2	$10.9M	Buy	72,390 +21,115	+41%	+$984K	0.23%	75
2019 Q1	$10.4M	Sell	51,275 -93,239	-65%	-$4.64M	0.23%	82
2018 Q4	$7.51M	Sell	144,514 -19,005	-12%	-$1.02M	0.2%	121
2018 Q3	$10.1M	Buy	163,519 +150,770	+1,183%	+$8.95M	0.21%	94
2018 Q2	$707K	Sell	12,749 -46,354	-78%	-$2.5M	0.01%	1204
2018 Q1	$3.74M	Sell	59,103 -108,356	-65%	-$6.97M	0.08%	274
2017 Q4	$10.3M	Buy	167,459 +16,070	+11%	+$1.01M	0.22%	60
2017 Q3	$9.61M	Buy	+151,389	New	+$8.84M	0.19%	76

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Oxford Asset Management's BMY Position: Q2 2026 in Review

Oxford Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 3,707 shares — an estimated $225K sold.

Oxford Asset Management first reported a position in BMY in Q3 2017 and held it in 13 quarters. The position peaked at $10.9M in Q2 2019. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Oxford Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 3,707 Bristol-Myers Squibb shares in Q2 2026, an estimated $225K.
Oxford Asset Management first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 13 quarters.
Oxford Asset Management's Bristol-Myers Squibb position peaked at $10.9M in Q2 2019.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.